Week in Review: Study of Potential COVID-19 Vaccine Shows Promise


Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

5. Phase 1 Study of Potential COVID-19 Vaccine Shows Promise

Positive interim clinical data of the mRNA-1273 vaccine (Moderna, Inc) against the coronavirus disease 2019 (COVID-19) were reported from a phase 1 study led by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH). Read more.

4. NACDS Urges Government to Consider Pharmacies’ Critical Role in COVID-19 Prevention

To support the successful reopening of the country in a manner that prevents further COVID-19 outbreaks, the National Association of Chain Drug Stores has issued a report in which it urges government action on 3 key objectives related to testing, contact tracing, and vaccines or treatments. Read more.

3. Structuring COVID-19 Protocols for Pharmacies

This article helps to provide guidance to pharmacies on structuring an appropriate written protocol that implements necessary controls, including what reliable governmental sources a pharmacy can turn to for COVID-19 guidance, recommended controls for pharmacy employees, and recommended controls for pharmacy patients. Read more.

2. NIH Study to Investigate Pregnancy Outcomes Resulting from COVID-19 Pandemic

The NIH has launched a multipronged study to further evaluate the effects of the COVID-19 pandemic during and after pregnancy. Read more.

1. Pharmacists’ Role in Tackling Social Determinants of Health

Social determinants of health have become a prominent buzz word in the health care industry over the past few years due to conditions in which people live, learn, work, and play affecting their health risks and outcomes, according to a session at the Pharmacy Quality Alliance 2020 Annual Meeting. Read here.

Related Videos
Image credit: terovesalainen - stock.adobe.com
ipopba - stock.adobe.com
Technician- © pharmacytimes
© 2024 MJH Life Sciences

All rights reserved.